She says K Health, for example, has strict criteria for prescribing GLP-1 agonist medications to ensure theyre only going to patients who really need them
In this regard, orforglipron is compared head-to-head with oral semaglutide
Its sold under the name Mounjaro, and while its still being studied specifically for weight loss, its already being used in lots of medspa programs because of how well it performs
Mulrow et al
The skeptical cardiologist, like most physicians, has always assumed that weight loss, whether accomplished by diet/exercise, bariatric surgery, or drugs would benefit obese patients since it results in lower blood pressure, improved cholesterol, and less diabetes but until the SELECT RCT was published we lacked solid evidence that any weight reduction therapy would lower the risk of heart attack, stroke, and cardiovascular death